-
akshay posted an update in the group
3 months agoPharma News 3 months agoIndia OKs Self-Certification for 1,000+ Medical Devices — A Doctor’s Take
As a clinician, I welcome any move that speeds access to safe, affordable equipment—but only if safety keeps pace. India will now allow self-certification for over a thousand low- to moderate-risk medical devices (think stethoscopes, wheelchairs, swabs, scissors). The aim…
-
neha posted an update in the group
3 months agoPharma News 3 months agoQuality-Check Crackdown: Doctors Alerted as Regulators Clamp Down on Faulty Licences
As a physician, recent regulatory action in India feels like a wake-up call. Senior officials announced that any pharma firm found submitting fake or misleading documents to obtain licences will face immediate bans under new amendments to the Central Drugs…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoFrom the Clinic: Why the Recent Pharma-Quality Crisis Hits Us Doctors at the Bedside
As a physician, the recent developments in India’s pharmaceutical industry have been deeply unsettling. Authorities have issued a hard-hitting advisory after discovering that multiple manufacturing facilities failed to test every batch of raw materials or…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoWhy Pharma and Physicians Must Connect Beyond the Trial
In my practice, the moment a new drug emerges from trials into the real world, everything changes. While randomized controlled trials give us foundational safety and efficacy, it’s real-world evidence (RWE) that reveals how treatments perform in everyday settings—across comorbidities,…
-
neha posted an update in the group
3 months agoPharma News 3 months agoDigital Roundtables: Redefining Pharma-Physician Engagement
In my daily practice, I’ve noticed how quickly the dynamic between pharmaceutical companies and physicians has shifted—and it’s all moving online. These days, digital roundtables are becoming the primary forum for meaningful engagement.
Instead of crowded conference halls and…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoVirtual Meetings: The New Bridge Between Pharma and Physicians
As a doctor, I’ve seen a major transformation in how the pharmaceutical industry connects with healthcare professionals — and it’s all thanks to virtual meetings. What used to be long in-person sessions or conferences has now evolved into focused, efficient digital…
-
neha posted an update in the group
3 months agoPharma News 3 months agoHow Physician Networking Communities Are Reshaping Patient Care
As a practicing doctor, I’ve come to realize that no single clinician can hold all the answers — especially in today’s rapidly evolving medical landscape. That’s where physician networking communities are proving transformative.
Platforms like HealthSocial are not just…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoHow Artificial Intelligence Is Transforming Communication Across Pharma
As a doctor, I’ve always believed that the foundation of good healthcare lies in communication — between clinicians, patients, researchers, and the pharmaceutical industry. Yet, for decades, that communication has often been fragmented and slow. Today, Artificial…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCollaborative Platforms: The New Prescription for Healthcare Innovation
As a doctor, I’ve witnessed how digital collaboration platforms are transforming the healthcare industry. Platforms like HealthSocial allow doctors, researchers, and pharma professionals to exchange ideas instantly — breaking silos that once slowed progress.
Whether it’s…
-
neha posted an update in the group
3 months agoPharma News 3 months agoSupreme Court Clears Natco’s Generic Risdiplam: A Win for Patients, a Lesson for Pharma
As a doctor, I see this week’s Supreme Court verdict — allowing Natco Pharma to launch its generic version of Risdiplam — as a landmark moment for both patients and the healthcare ecosystem. Risdiplam is a life-changing drug for Spinal Muscular Atrophy…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCough Syrup Tragedy Exposes Fragility in India’s Drug Safety Oversight
As a clinician deeply invested in both patient safety and pharmaceutical integrity, recent events surrounding contaminated cough syrups in India have shaken me to the core. This isn’t just “another pharma scandal” — it’s a stark warning that regulatory gaps, quality lapses,…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoThe Rise of Indian Pharma Exports: What It Means for Healthcare Professionals
As a doctor, I’ve always viewed India’s pharmaceutical sector with a sense of pride — it’s often called “the pharmacy of the world.” Over the past decade, Indian pharma exports have grown remarkably, supplying affordable and quality medicines to more than 200…
-
neha posted an update in the group
3 months agoPharma News 3 months agoIndia’s Pharma Evolution: A Doctor’s Perspective on Progress and Responsibility
As a practising doctor, I see the rapid transformation of India’s pharmaceutical industry not just as industry news, but as something that directly impacts patient care, prescribing habits, and trust in our healthcare system.
Affordability remains a key focus. The…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoIndia’s Premier Med Systems Investing ₹60 Crore to Expand Device Manufacturing at Noida Park
As a physician who often deals with shortages or long lead times for imaging and critical care equipment, this update is very encouraging. Premier Medical Systems (Medisys), one of India’s earliest medical-equipment makers, has secured a letter of…
-
neha posted an update in the group
4 months agoPharma News 4 months agoIndia’s Medical Device Market Poised for Significant Growth by 2033
India’s medical device market is set to expand from USD 6.82 billion in 2025 to approximately USD 12.57 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.00%. This growth is driven by increased healthcare investment, government support, and…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoIndia’s Drug Regulatory Authority Approves Eight New Medicines in 2025, Expanding Treatment Options Across Multiple Therapeutic Areas
The Central Drugs Standard Control Organisation (CDSCO) has approved eight new medicines in 2025, marking a significant step forward in India’s healthcare sector. These approvals encompass a range of…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoSafer Eye Chemo for Kids: Intravitreal Topotecan Success in Retinoblastoma
In Hyderabad, the LV Prasad Eye Institute (LVPEI) ran a study in children with retinoblastoma (a rare but serious eye cancer). Traditionally, recurrences or resistant tumors are treated with intravitreal injections of melphalan, but at higher doses that can damage…
-
neha posted an update in the group
4 months agoPharma News 4 months agoIndia’s Push for Biosimilars: Affordable Access to Life-Saving Drugs
In oncology and autoimmune care, I often see patients forced to discontinue treatment because the original biologic drug is too expensive. This is where biosimilars — near-identical versions of complex biologics — are changing lives in India.
Recently, Indian pharma…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoWearables: The Next Step Toward Truly Personalized Medicine
Recently, one of my heart patients showed me how his smartwatch had picked up irregular beats before he even felt symptoms. That moment reminded me how far we’ve come — and how much further we can go.
Wearables today track heart rate, sleep, oxygen levels, and even stress. But what…
-
neha posted an update in the group
4 months agoPharma News 4 months agoHow Companion Diagnostics Are Transforming Prescriptions
One change I’ve noticed in recent years is that prescribing is no longer just about choosing a drug — it’s about choosing the right drug for the right patient, backed by a diagnostic test. These are called companion diagnostics, and they’re becoming more common in cancer, infectious…
- Load More
